The iShares MSCI World ETF: Record Territory Meets a Triple Test

The iShares Core MSCI World ETF trades just below its record high at €116.80, but faces tests from Big Tech earnings, a May 2026 MSCI rebalancing, and rising fee competition.

The iShares Core MSCI World UCITS ETF (Acc) is trading at a whisper from its all-time high, yet the forces shaping its trajectory are anything but quiet. At €116.80, the fund sits just below the €116.87 peak set earlier this week, with a 12-month gain of roughly 28% and a year-to-date advance of 4.33% that underscores a resilient start to 2026. The 200-day moving average of €109.85 sits more than 6% below the current price, confirming an intact medium-term uptrend. But beneath the surface, three converging pressures are set to test the world’s largest ETF.

Earnings Season Puts the Heavyweights on the Clock

The fund’s composition is its own biggest stress test. US equities account for over 70% of the portfolio, with the technology sector alone representing roughly a quarter. The coming days bring critical results from two of the index’s titans: Microsoft reports on 29 April, followed by Apple a day later. Together with Nvidia, these three names command a combined 13.6% of the entire ETF’s weight.

For Microsoft, the focus will be on cloud revenue growth, while Apple’s forward guidance will be under the microscope. The numbers from these giants radiate directly through the entire index, meaning any disappointment could trigger a swift repricing across the fund’s core holdings. The neutral RSI reading of 49 and an annualized 30-day volatility of just under 15% suggest markets are not braced for fireworks — but earnings season has a habit of delivering surprises.

A Structural Overhaul Looms in May 2026

Beyond the quarterly noise, a more fundamental shift is brewing. MSCI will revise its free-float calculation methodology in May 2026, dividing publicly tradable shares into three distinct categories. Because the regular index rebalancing in March was unusually small, analysts now anticipate a significantly larger portfolio turnover when the new rules take effect. That means billions of dollars in tracking funds will need to be repositioned, potentially creating ripples through the underlying stocks.

The timing is delicate. The ETF’s assets under management stand at roughly $124 billion, making it the largest product of its kind. Any forced rebalancing at that scale can move markets, particularly in smaller index constituents where liquidity is thinner.

Fee Pressure and Sector Risks Mount

The competitive landscape is also heating up. Invesco cut the expense ratio on its MSCI World ETF to 0.05% in April, undercutting BlackRock’s 0.20% fee on the iShares fund by a wide margin. BlackRock’s defense rests on its tracking difference of just 0.02% — a measure of how closely the fund mirrors the index. So far, major investors are sticking with the market leader. The Royal Bank of Canada increased its position by 17.5% in late 2025, a vote of confidence that has helped the iShares fund defend its dominant market share.

But another risk is building on the sector front. The US government plans to impose new tariffs on imported pharmaceuticals from the end of July, a move that could weigh on healthcare stocks. That sector accounts for nearly 10% of the portfolio, and any tariff-related disruption would hit a meaningful chunk of the fund’s holdings.

What’s on the Horizon

June brings two notable events. On the 15th, the ETF will trade ex-dividend, a date income-focused investors will have circled. Earlier that month, SpaceX is targeting an initial public offering with an estimated valuation of $1.75 trillion. If the company is eventually added to the MSCI World index, it would further amplify the already heavy US weighting — a development that index purists and diversification advocates will watch closely.

For now, the iShares Core MSCI World ETF sits at a crossroads: record highs, a structural index shake-up, earnings from its biggest constituents, and a fee war that shows no signs of cooling. The next few weeks will reveal whether this triple test is a speed bump or something more significant.